Journal Guide

Frontiers of Medicine  is a general medical journal devoted to publishing original research and review articles on the latest advances in clinical and basic medicine with a focus on epidemiology, traditional Chinese medicine, translational research, healthcare, public health and health policies. The journal employs a rigorous peer-review and editing process to ensure the scientific accuracy, novelty and importance of the manuscripts. Frontiers of Medicine is committed to promoting health and health care through communications among professionals in medical care, disease prevention and scientific research throughout the world by updating the progress in medicine, sharing experiences in disease control and treatment and exchanging views on health policies, medical services and health care reform.

Future Oncology takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in a new era of cancer care. The journal includes news and views, literature awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. Accessible ‘at-a-glance’ formats are important in an increasingly time-constrained clinical community. The article structure has been optimized to make information immediately understandable and accessible.

The GAMO is a high-quality scientific journal (published both in print and freely available online format) that informs healthcare professionals on the most relevant and updated advances on research and education, in order to offer cancer patients multidisciplinary, state of the art care.

It is the official scientific and academic diffusion publication of the Mexican Society of Oncology (SMeO). Regular numbers are published every two months, in addition to several supplements throughout the year.

Its spaces are open to the SMeO members, as well as to any member of the medical community (both national and international) interested in using this publication to communicate his/her works under the standards of universal editorial policies.

It is the jornal of choice for oncologists in matters of research and education on surgical, medical, pediatric, gynecologic, hematologic and radiation oncology, as well as on detection, diagnosis, follow-up and rehabilitation supportive disciplines, fields where different specialties involved in the management of the cancer patient do participate.
About the journal

The mission of the GAMO consists in serving its readers in:

1. representation and promotion of the oncolgy profession throughout the country and the world
2. promotion of standards of the highest quality in the practice of multidisciplinary care for the cancer patient
3. providing educational materials on cancer and support the training of investigators, using printed and electronic media
4. promotion of both clinical and translational cancer research, with special emphasis on clinical trials
5. facilitate the professional development of trainee oncologists and their transition to academical practice, fostering the interest on care for the community
6. promotion of public policies and support and guidance instruments for the cancer patient.

The Editorial Board and Committee are comprised of different experts in the field of oncology from multiple institutions, both national and international. The Editorial Board is structured based on the editorial sections that reflect the contents of the journal. Each section is directed by a section editor who supervises peer reviewing of the works by experts on the relevant area or subject. The Editorial Board Members are regular collaborators of the journal and are appointed to a 2-year period. The Editor in Chief has a 4-year period with option to a second period for the same time.
Publication guidelines

The journal is subject to international publication guidelines that indicate how a manuscript must be prepared to be able to be published, aspects on edition and publication of articles and ethical considerations that have to be followed in the communication of results.
Article types

The journal includes several types of articles. According to the structure, focus, contents, scope and purposes of the document, they can be classified as:

• Editorial
• Original articles
• Review articles
• Clinical cases

The articles can support their proposals, findings and conclusions using tables and images.

The articles are subject to peer review as a control method with regard to quality and veracity of the contents.

Submission: electronic format or by postal mail. The articles are published online in the website and sent to the SMeO members.

Gastric Cancer, a joint official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, publishes significant studies related to stomach neoplasms. The journal welcomes original articles, case reports, short communications, and technical notes, which will be peer-reviewed by the editorial board. Letters to the Editor commenting on articles published in the journal or expressing views on topics concerning gastric cancer are also welcomed. Review articles are in principle solicited by the Editor. Meeting reports will include summaries of symposia or consensus achieved in the congresses of related associations.

As the official journal of the Society of Gastrointestinal Intervention, Gastrointestinal Intervention delivers original, peer-reviewed articles for the gastroenterologists, interventional radiologists, surgeons, gastrointestinal oncologists, nurses and technicians who need current and reliable information on the interventional treatment of gastrointestinal and hepatopancreaticobiliary diseases. Regular features also include 'the state of art' review articles by leading authorities throughout the world. Gastrointestinal Intervention will become an international forum for the description and discussion of the various aspects of interventional radiology, endoscopy and minimal invasive surgery.
The Journal is published every 6 months since December 2012.

Gastrointestinal Tumors is an international, peer-reviewed journal that brings together the leading opinions in all fields related to gastrointestinal cancer research. Ranging from the identification of new therapeutic targets to epidemiology, disease prevention, treatment, and patient management, the journal provides a platform for the dissemination of key opinions and research from thought leaders in the field. By publishing timely reviews and original papers covering the latest developments, the journal helps readers to gain insight into the evolving body of research across the relevant disciplines.

Genes, Chromosomes & Cancer will offer rapid publication of original full-length research articles , perspectives , reviews , letters to the editors , as well as editorial commentaries on genetic analysis as related to the study of neoplasia. Particular emphasis will be placed on work combining molecular and cytogenetic analyses of the genomic alterations of cancer cells. While preference will be given to research using analytical approaches, descriptive studies and case reports will also be welcomed, particularly when they offer insights regarding basic biologic mechanisms or the clinical management of neoplastic disorders. Specific areas covered will include:

Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.Research Areas Include:• Cell and molecular biology• Chemotherapy• Cytology• Endocrinology• Epidemiology• Genetics• Gynecologic surgery• Immunology• Pathology• RadiotherapyBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.

All manuscripts will be peer reviewed according to the Journal's policy set out below and, if accepted for publication in the Journal, Authors will be notified of this decision and at the same time requested to pay an Article Processing Fee. Following payment of the Article Processing Fee, papers will be made open access. Letters to the editor which comment upon work previously published in either Gynecologic Oncology or Gynecologic Oncology Reports will be published free of charge.

This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).

Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.

All manuscripts will be peer reviewed according to the Journal's policy set out below and, if accepted for publication in the Journal, Authors will be notified of this decision and at the same time requested to pay an Article Processing Fee. Following payment of the Article Processing Fee, papers will be made open access. Letters to the editor which comment upon work previously published in either Gynecologic Oncology or Gynecologic Oncology Reports will be published free of charge.

This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/journals/gynecologic-oncology-reports/2352-5789/guide-for-authorsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Effective with the 2011 volume, this journal will be published in an online-only format Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:

Hematology/Oncology Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers8212;bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.
Hematology/Oncology Clinics of North America is published six times each year, in February, April, June, August, October, and December.

Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value.